Eileen Duenas

3.3k total citations
16 papers, 1.4k citations indexed

About

Eileen Duenas is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eileen Duenas has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eileen Duenas's work include Growth Hormone and Insulin-like Growth Factors (6 papers), Protein purification and stability (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Eileen Duenas is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (6 papers), Protein purification and stability (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Eileen Duenas collaborates with scholars based in United States, France and Switzerland. Eileen Duenas's co-authors include Jeffrey L. Cleland, Andrew J. S. Jones, Ann L. Daugherty, Xanthe M. Lam, Scott D. Putney, Douglas Shepard, Jeffrey L. Cleland, Hyejung Lee, Kelly A. Schwarz and William J. Galush and has published in prestigious journals such as Nature Medicine, Cancer Research and Journal of Controlled Release.

In The Last Decade

Eileen Duenas

16 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen Duenas United States 14 635 508 414 225 209 16 1.4k
Flávia Sousa Portugal 24 574 0.9× 402 0.8× 701 1.7× 531 2.4× 132 0.6× 37 1.6k
Lena H. Hwang United States 11 1.1k 1.7× 316 0.6× 293 0.7× 174 0.8× 37 0.2× 11 1.9k
Arash Hatefi United States 25 1.1k 1.8× 332 0.7× 630 1.5× 377 1.7× 124 0.6× 57 2.1k
Cian M. McCrudden United Kingdom 32 1.4k 2.3× 1.2k 2.4× 217 0.5× 279 1.2× 83 0.4× 52 3.1k
Yizong Hu United States 16 690 1.1× 204 0.4× 205 0.5× 214 1.0× 34 0.2× 20 1.2k
João P. Martins Finland 16 270 0.4× 222 0.4× 283 0.7× 350 1.6× 65 0.3× 29 930
Robert Langer United States 8 475 0.7× 183 0.4× 286 0.7× 282 1.3× 40 0.2× 10 1.2k
Sung Wan Kim United States 22 1.3k 2.0× 96 0.2× 529 1.3× 302 1.3× 49 0.2× 44 2.0k
Cyrus Tabatabay Switzerland 22 197 0.3× 382 0.8× 287 0.7× 123 0.5× 230 1.1× 41 1.1k
Vibhuti Agrahari United States 19 754 1.2× 436 0.9× 420 1.0× 341 1.5× 290 1.4× 33 1.8k

Countries citing papers authored by Eileen Duenas

Since Specialization
Citations

This map shows the geographic impact of Eileen Duenas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Duenas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Duenas more than expected).

Fields of papers citing papers by Eileen Duenas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Duenas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Duenas. The network helps show where Eileen Duenas may publish in the future.

Co-authorship network of co-authors of Eileen Duenas

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Duenas. A scholar is included among the top collaborators of Eileen Duenas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Duenas. Eileen Duenas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chan, Phyllis, Zhilan Hu, Amy Shen, et al.. (2022). C-Terminal Lysine Processing of IgG in Human Suction Blister Fluid: Implications for Subcutaneous Administration. Molecular Pharmaceutics. 19(11). 4043–4054. 5 indexed citations
2.
Jiang, Guoying, Christopher Yu, Daniela Bumbaca Yadav, et al.. (2016). Evaluation of Heavy-Chain C-Terminal Deletion on Product Quality and Pharmacokinetics of Monoclonal Antibodies. Journal of Pharmaceutical Sciences. 105(7). 2066–2072. 23 indexed citations
3.
Schwarz, Kelly A., et al.. (2014). Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload. Bioconjugate Chemistry. 25(4). 656–664. 158 indexed citations
4.
Schwall, Ralph, Zhong Zheng, Elaine Mai, et al.. (2004). Inhibition of cMet activation by a one-armed antibody. Cancer Research. 64. 327–327. 10 indexed citations
5.
Cleland, Jeffrey L., Eileen Duenas, Ann L. Daugherty, et al.. (2001). Development of poly-(d,l-lactide–coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. Journal of Controlled Release. 72(1-3). 13–24. 171 indexed citations
6.
Lam, Xanthe M., Eileen Duenas, & Jeffrey L. Cleland. (2001). Encapsulation and stabilization of nerve growth factor into poly(lactic‐co‐glycolic) acid microspheres. Journal of Pharmaceutical Sciences. 90(9). 1356–1365. 75 indexed citations
7.
Duenas, Eileen, et al.. (2001). Comparison between light induced and chemically induced oxidation of rhVEGF.. Pharmaceutical Research. 18(10). 1455–1460. 32 indexed citations
8.
Lam, Xanthe M., Eileen Duenas, Ann L. Daugherty, Nathan W. Levin, & Jeffrey L. Cleland. (2000). Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. Journal of Controlled Release. 67(2-3). 281–292. 112 indexed citations
9.
Saltzman, W. Mark, et al.. (1999). Intracranial Delivery of Recombinant Nerve Growth Factor: Release Kinetics and Protein Distribution for Three Delivery Systems. Pharmaceutical Research. 16(2). 232–240. 82 indexed citations
10.
Cleland, Jeffrey L., Amy Lim, Ann L. Daugherty, et al.. (1998). Development of a single‐shot subunit vaccine for HIV‐1. 5. Programmable in vivo autoboost and long lasting neutralizing response. Journal of Pharmaceutical Sciences. 87(12). 1489–1495. 24 indexed citations
11.
Cleland, Jeffrey L., Ben J. Boyd, Janet G. Yang, et al.. (1997). The Stability of Recombinant Human Growth Hormone in Poly(lactic-co-glycolic acid) (PLGA) Microspheres. Pharmaceutical Research. 14(4). 420–425. 87 indexed citations
12.
Lee, Hyejung, O. Johnson, Jeffrey L. Cleland, et al.. (1997). In Vivo Characterization of Sustained-Release Formulations of Human Growth Hormone. Journal of Pharmacology and Experimental Therapeutics. 281(3). 1431–1439. 75 indexed citations
13.
Cleland, Jeffrey L., Amy Lim, Lorena Barrón, Eileen Duenas, & Michael F. Powell. (1997). Development of a single-shot subunit vaccine for HIV-1: Part 4. Optimizing microencapsulation and pulsatile release of MN rgp120 from biodegradable microspheres. Journal of Controlled Release. 47(2). 135–150. 66 indexed citations
14.
Cleland, Jeffrey L., Eileen Duenas, Douglas Shepard, et al.. (1997). The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres. Pharmaceutical Research. 14(6). 730–735. 176 indexed citations
15.
Cleland, Jeffrey L., Eileen Duenas, Ann L. Daugherty, et al.. (1997). Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. Journal of Controlled Release. 49(2-3). 193–205. 54 indexed citations
16.
Cleland, Jeffrey L., Hyejung Lee, Eileen Duenas, et al.. (1996). A month–long effect from a single injection of microencapsulated human growth hormone. Nature Medicine. 2(7). 795–799. 248 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flávia Sousa Breakdown of academic impact, for papers by Lena H. Hwang Breakdown of academic impact, for papers by Arash Hatefi Breakdown of academic impact, for papers by Cian M. McCrudden Breakdown of academic impact, for papers by Yizong Hu Breakdown of academic impact, for papers by João P. Martins Breakdown of academic impact, for papers by Robert Langer Breakdown of academic impact, for papers by Sung Wan Kim Breakdown of academic impact, for papers by Cyrus Tabatabay Breakdown of academic impact, for papers by Vibhuti Agrahari
Rankless by CCL
2026